Skip to main content
. 2019 Feb 5;27(2):253–260. doi: 10.3727/096504018X15242763477504

Figure 6.

Figure 6

miR-1284 suppressed PI3K/AKT pathway by targeting ZIC2 in breast cancer cells. Western blot was used to measure the activation of the PI3K/AKT pathway.